CMS Expects 'Consistent' Coverage Of Amyloid PET Scans Even Without National Standard

Medicare has finally rescinded its 10-year-old national restrictions on covering the diagnostic now that advances in amyloid plaque-removing drugs have underscored the importance of PET scans.